
K00135
CAS No. 869650-21-5
K00135 ( K-00135 | K 00135 | IMIDAZOPYRIDAZIN 1 | Imidazol[1,2-b]pyridazine 1 )
产品货号. M27892 CAS No. 869650-21-5
K00135 是 Pim 激酶的选择性抑制剂,可用于胃癌和抗白血病治疗的研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥2373 | 有现货 |
![]() ![]() |
5MG | ¥3637 | 有现货 |
![]() ![]() |
10MG | ¥5338 | 有现货 |
![]() ![]() |
25MG | ¥7995 | 有现货 |
![]() ![]() |
50MG | ¥11259 | 有现货 |
![]() ![]() |
100MG | ¥15228 | 有现货 |
![]() ![]() |
500MG | ¥30618 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称K00135
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述K00135 是 Pim 激酶的选择性抑制剂,可用于胃癌和抗白血病治疗的研究。
-
产品描述K00135 is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.(In Vitro):K00135 dose-dependently impairs the survival of murine Ba/F3 cells that have been rendered cytokine independent by overexpression of human PIMs. K00135 impairs survival and clonogenic growth of a panel of human acute leukemia cells. Exposure of K00135 significantly suppresses in vitro growth of leukemic blasts from five acute myelogenous leukemia patients but not of normal umbilical cord blood mononuclear cells.
-
体外实验——
-
体内实验——
-
同义词K-00135 | K 00135 | IMIDAZOPYRIDAZIN 1 | Imidazol[1,2-b]pyridazine 1
-
通路JAK/STAT Signaling
-
靶点Pim
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number869650-21-5
-
分子量306.36
-
分子式C18H18N4O
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(C1=CC=CC(=C1)C2=CN=C3C=CC(=NN32)NCC4CC4)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Honda S, Toyota T. Photo-triggered solvent-free metamorphosis of polymeric materials. Nat Commun. 2017 Sep 11;8(1):502.